Advertisement

The Virus as the Etiologic Agent of Infectious Mononucleosis

  • G. Henle
  • W. Henle

Abstract

The world-wide distribution and high incidence of antibodies to the Epstein-Barr virus (EBV) (see Chap. 4) strongly suggested that the virus might be the unsuspected cause of a common disease, besides its association with two rare malignancies i.e., Burkitt’s lymphoma (BL) and nasopharyngeal carcinoma (NPC). Consequently, numerous paired acute-phase and convalescent sera from patients with unidentifiable infections of presumably viral origin were examined for an emergence or increase in titer of antibodies to EBV. While these efforts in search of a disease caused by the virus were initially unrewarding, they prepared the stage for what appeared to be a fortuitous observation and led to the identification of EBV as the long-sought cause of infectious mononucleosis (IM).

Keywords

Infectious Mononucleosis Lymphoid Cell Line Phosphonoacetic Acid Throat Washing Acute Infectious Mononucleosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Armstrong, D., Henle, G., Henle, W.: Complement fixation tests with cell lines derived from Burkitt’s lymphoma and acute leukemias. J. Bacteriol. 91, 1257–1262 (1966)PubMedGoogle Scholar
  2. Aya, T., Osato, T.: Early events in transformation of human cord leukocytes by Epstein-Barr virus; Induction of DNA synthesis and virus-associated nuclear antigen. Int. J. Cancer 13, 341–347 (1974)CrossRefGoogle Scholar
  3. Banatvala, J. E., Best, J. M., Waller, D. K.: Epstein-Barr virus-specific IgM in infectious mononucleosis, Burkitt’s lymphoma, and nasopharyngeal carcinoma. Lancet 1972 I, 1205–1208CrossRefGoogle Scholar
  4. Bar, R., DeLor, C. L., Clausen, K. P., Hurtubise, P., Henle, W., Hewetson, J.: Fatal infectious mononucleosis in a family. N. Engl. J. Med. 290, 363–367 (1974)PubMedCrossRefGoogle Scholar
  5. Bentzon, J. W.: The effect of certain infectious diseases on tuberculin allergy. Tubercle 34, 34–41 (1955)CrossRefGoogle Scholar
  6. Blacklow, N. R., Watson, B. K., Miller, G., Jacobson, B. M.: Mononucleosis with heterophil antibodies and EB virus infection. Acquisition by an elderly patient in hospital. Am. J. Med. 51, 549–552 (1971)PubMedCrossRefGoogle Scholar
  7. Britton, S., Andersson-Anvret, M., Gergely, P., Henle, W., Jondal, M., Klein, G., Sandstedt, B., Svedmyr, G.: EB virus immunity and tissue distribution in a fatal case of infectious mononucleosis. N. Engl. J. Med. 298, 89–92 (1978)PubMedCrossRefGoogle Scholar
  8. Carter, R. L.: Antibody formation in infectious mononucleosis. II. Other 19S antibodies and false-positive serology. Br. J. Hemattol. 12, 268–275 (1966)CrossRefGoogle Scholar
  9. Chang, R. S., Golden, H. D.: Transformation of human leukocytes by throat washing from infectious mononucleosis patients. Nature 234, 359–360 (1971)PubMedCrossRefGoogle Scholar
  10. Chang, R. S., Lewis, J. P., Abildgaard, C. F.: Prevalance of oropharyngeal excretors of leukocyte-transforming agents among a human population. N. Engl. J. Med. 289, 1325–1329 (1973)PubMedCrossRefGoogle Scholar
  11. Crawford, D. H., Rickinson, A. B., Finerty S., Epstein, M. A.: Epstein-Barr (EB) virus genome-containing, EB nuclear antigen-negative B-lymphocyte populations in blood in acute infectious mononucleosis. J. Gen. Virol. 38, 449–460 (1978)PubMedCrossRefGoogle Scholar
  12. Davidsohn, I., Lee, C. L.: Serologic diagnosis of infectious mononucleosis. A comparative study of five tests. Am. J. Clin. Pathol. 41, 115–125 (1964)PubMedGoogle Scholar
  13. Dalens, M., Zech, L., Klein, G.: Origin of lymphoid lines established from mixed cultures of cord blood lymphocytes and expiants from infectious mononucleosis, Burkitt lymphoma and healthy donors. Int. J. Cancer 16, 1008–1014 (1975)PubMedCrossRefGoogle Scholar
  14. Davidsohn, I., Nelson, D. A.: The blood. In: Todd-Sanford’s clinical diagnosis by laboratory methods, 14th ed. Davidsohn, I., Henry, J. B. (eds.), Chap. 5. Philadelphia: Saunders 1969Google Scholar
  15. De Schryver, A., Klein, G., Hewetson, J., Rocchi, G., Henle, W., Henle, G., Pope, J.: Comparison of EBV neutralization tests based on abortive infection or transformation of lymphoid cells and their relation to membrane reactive antibodies (anti-MA). Int. J. Cancer 13, 353–362 (1974)PubMedCrossRefGoogle Scholar
  16. Deinhardt, F., Falk, L., Wolfe, L. G., Paciga, J., Johnson, D.: Response of marmosets to experimental infection with Epstein-Barr virus. In: Oncogenesis and herpesviruses II. de-Thé, G., Epstein, M. A., zur Hausen, H. (eds.), Part 2, pp. 161–168. Lyon: IARC 1975Google Scholar
  17. Diehl, V., Henle, G., Henle, W., Kohn, G.: Demonstration of a herpes group virus in cultures of peripheral leukocytes from patients with infectious mononucleosis. J. Virol. 2, 663–669 (1968)PubMedGoogle Scholar
  18. Dorfman, R. F., Warnke, R.: Lymphadenopathy simulating the malignant lymphomas. Human Pathol. 5, 519(1974)CrossRefGoogle Scholar
  19. Dunkel, V., Pry, T., Henle, G., Henle, W.: Immunofluorescence tests for antibodies to Epstein-Barr virus with sera of lower primates. J. Nat. Cancer Inst. 49, 435–440 (1972)PubMedGoogle Scholar
  20. Edwards, J. M. B., McSwiggan, D. A.: Studies on the diagnostic value of an immunofluorescence test for EB virus-specific IgM. J. Clin. Pathol. 27, 647–651 (1974)PubMedCrossRefGoogle Scholar
  21. Enberg, R. N., Eberle, B. J., Williams, C. R. (Jr.): T- and B-cells in peripheral blood during infectious mononucleosis. J. Infect. Dis. 130, 104–111 (1974)PubMedCrossRefGoogle Scholar
  22. Epstein, A. L., Levy, R., Henle, W., Henle, G., Kaplan, H. S.: Biology of the human malignant lymphomas: IV. Functional characterization of 10 diffuse histiocytic lymphoma cell lines. Cancer 42, 2379–2391 (1978)PubMedCrossRefGoogle Scholar
  23. Epstein, M. A., Achong, B. G., Barr, Y. M.: Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet 1964 I, 702–703CrossRefGoogle Scholar
  24. Epstein, M. A., Henle, G., Achong, B. G., Barr, Y. M.: Morphological and biological studies on a virus in cultured lymphoblasts from Burkitt’s lymphoma. J. Exp. Med. 121, 761–770 (1965)PubMedCrossRefGoogle Scholar
  25. Ernberg, I., Klein, G., Kourilsky, F. M., Silvestre, D.: Differentiation between early and late membrane antigen on human lymphoblastoid cell lines infected with Epstein-Barr virus. I. Immunofluorescence. J. Natl., Cancer Inst. 53, 61–65 (1974)Google Scholar
  26. Evans, A. S.: Experimental attempts to transmit infectious mononucleosis to man. Yale J. Biol. Med. 20, 19–26 (1947)PubMedGoogle Scholar
  27. Evans, A. S.: Further experimental attempts to transmit infectious mononucleosis to man. J. Clin. Invest. 29, 508–512 (1950)PubMedCrossRefGoogle Scholar
  28. Evans, A. S., Evans, B. K., Sturtz, V.: Standards for hepatic and hematologic tests in monkeys: Observations during experiments with hepatitis and mononucleosis. Proc. Soc. Exp. Biol. Med. 82, 437–440 (1953)PubMedGoogle Scholar
  29. Evans, A. S., Niederman, J. C., McCollum, R. W.: Seroepidemiologic studies of infectious mononucleosis with EB virus. N. Engl. J. Med. 279, 1121–1127 (1968)PubMedCrossRefGoogle Scholar
  30. Evans, A. S., Niederman, J. C., Canabre, L. C., West, B., Richards, V. A.: A prospective evaluation of heterophile and Epstein-Barr virus-specific IgM antibody tests in clinical and subclinical infectious mononucleosis: Specificity of and sensitivity of the tests and persistance of antibody. J. Infect. Dis. 132, 546–554 (1975)PubMedCrossRefGoogle Scholar
  31. Galloway, E.: Comparison of three slide tests for infectious mononucleosis with Davidsohn’s presumptive and differential heterophil test. Canad. J. Med. Technol. 31, 197–206 (1969)Google Scholar
  32. Gerber, P.: Activation of Epstein-Barr virus by 5-bromodeoxyuridine in “virus-free” human cells. Proc. Natl. Acad. Sci. USA 69, 83–85 (1972)PubMedCrossRefGoogle Scholar
  33. Gerber, P., Deal, D. R.: Epstein-Barr virus-induced viral and soluble complement-fixing antigens in Burkitt’s lymphoma cell cultures. Proc. Soc. Exp. Biol. Med. 134, 748–751 (1970)PubMedGoogle Scholar
  34. Gerber, P., Hamre, D., Moy, R. A., Rosenblum, E. N.: Infectious mononucleosis: Complement-fixing antibodies to herpes-like virus associated with Burkitt’s lymphoma. Science 161, 173–175 (1968)PubMedCrossRefGoogle Scholar
  35. Gerber, P., Whang-Peng, J., Monroe, J. H.: Transformation and chromosome changes induced by Epstein-Barr virus in normal human leukocyte cultures. Proc. Nat. Acad. Sci. USA 63, 740–747 (1969 a)CrossRefGoogle Scholar
  36. Gerber, P., Walsh, J. H., Rosenblum, E. N., Purcell, R. H.: Association of EB virus infection with the post-perfusion syndrome. Lancet 1969 b I, 593–596CrossRefGoogle Scholar
  37. Gerber, P., Nonoyama, M., Lucas, S., Perlin, E., Goldstein, L. I.: Oral excretion of Epstein-Barr virus by healthy subjects and patients with infectious mononucleosis. Lancet 1972 II, 988–989CrossRefGoogle Scholar
  38. Gerber, P., Pritchett, R. F., Kieff, E. D.: Antigens and DNA of a chimpanzee agent related to Epstein-Barr virus. J. Virol. 19, 1090–1099 (1976)PubMedGoogle Scholar
  39. Gergely, L., Klein, G., Ernberg, I.: The action of DNA antagonists on Epstein-Barr virus (EBV)-associated early antigens (EA) in Burkitt lymphoma lines. Int. J. Cancer 7, 293–302 (1971 a)PubMedCrossRefGoogle Scholar
  40. Gergely, L., Klein, G., Ernberg, I.: Effect of EBV-induced early antigens on host macromolecular synthesis, studied by combined immunofluorescence and radioautography. Virology 45, 22–29 (1971b)PubMedCrossRefGoogle Scholar
  41. Ginsburg, C. M., Henle, G., Henle, W.: An outbreak of infectious mononucleosis among the personnel of an outpatient clinic. Am. J. Epidemiol. 104, 571–575 (1976)PubMedGoogle Scholar
  42. Ginsburg, C. M., Henle, W., Henle, G., Horwitz, C. A.: Infectious mononucleosis in children: evaluation of the Epstein-Barr virus-specific serology. J. Am. Med. Assoc. 237, 781–785 (1977)CrossRefGoogle Scholar
  43. Giulano, V. J., Jasin, H. A., Ziff, M.: The nature of the atypical lymphocyte in infectious mononucleosis. Clin. Immunol. Immunopathol. 3, 90–98 (1974)CrossRefGoogle Scholar
  44. Glade, P. R., Karel, J. A., Morse, H. L., Whang-Peng, J., Hoffman, P. E., Kammermeyer, J. K., Chessin, L. N.: Infectious mononucleosis continuous suspension cultures of peripheral leukocytes. Nature 217, 564–565 (1968)PubMedCrossRefGoogle Scholar
  45. Grose, C., Henle, W., Henle, G., Feorino, P. M.: Primary Epstein-Barr virus infections in acute neurologic diseases. N. Engl. J. Med. 292, 392–395 (1975)PubMedCrossRefGoogle Scholar
  46. Grose, C., Henle, W., Horwitz, M. S.: Primary Epstein-Barr virus infection in a renal transplant recipient. South. Med. J. 70, 1276–1278 (1978)CrossRefGoogle Scholar
  47. Haider, S., Coutino, M. D., Emond, R. T. D.: Tuberculin anergy and infectious mononucleosis. Lancet 1973 II, 74CrossRefGoogle Scholar
  48. Hallee, T. J., Evans, A. S., Niederman, J. C.: Infectious mononucleosis at the United States Military Academy. A prospective study of a single class over 4 years. Yale J. Biol. Med. 47, 182–192 (1974)PubMedGoogle Scholar
  49. Hampar, B., Hsu, K. C., Martos, L. M., Walker, J. L.: Serologic evidence that a herpes-type virus is the etiologic agent of heterophile-positive infectious mononucleosis. Proc. Natl. Acad. Sci. USA 68, 1407–1411 (1971)PubMedCrossRefGoogle Scholar
  50. Hampar, B., Derge, J. G., Martos, L. M., Walker, J. L.: Synthesis of Epstein-Barr virus after activation of the viral genome in a “virus-negative” human lymphoblastoid cell (Raji) made resistant to 5-bromodeoxyuridine. Proc. Natl. Acad. Sci. USA 69, 78–82 (1972)PubMedCrossRefGoogle Scholar
  51. Henle, G., Henle, W.: Immunofluorescence in cells derived from Burkitt’s lymphoma. J. Bacteriol. 91, 1248–1256 (1966)PubMedGoogle Scholar
  52. Henle, G., Henle, W.: Immunofluorescence, interference and complement fixation techniques in the detection of the herpes-type virus in Burkitt tumor cell lines. Cancer Res. 27, 2442–2446 (1967)PubMedGoogle Scholar
  53. Henle, G., Henle, W.: Observations on childhood infections with the Epstein-Barr virus. J. Infect. Dis. 121, 303–310 (1970)PubMedCrossRefGoogle Scholar
  54. Henle, G., Henle, W., Diehl, V.: Relation of Burkitt tumor associated herpes-type virus to infectious mononucleosis. Proc. Natl. Acad. Sci. USA 59, 94–101 (1968)PubMedCrossRefGoogle Scholar
  55. Henle, G., Henle, W., Klein, G.: Demonstration of two distinct components in the early antigen complex of Epstein-Barr virus infected cells. Int. J. Cancer 8, 272–282 (1971)PubMedCrossRefGoogle Scholar
  56. Henle, G., Henle, W., Horwitz, C. A.: Antibodies to Epstein-Barr virus-associated nuclear antigen in infectious mononucleosis. J. Infect. Dis. 130, 231–239 (1974)PubMedCrossRefGoogle Scholar
  57. Henle, W., Henle, G.: Epstein-Barr virus: The cause of infectious mononucleosis. In: Oncogenesis and herpesviruses. Biggs, P. M., de-Thé, G., Payne, L. N. (eds.), pp. 269–274. Lyon: IARCGoogle Scholar
  58. Henle, W., Henle, G.: Epstein-Barr virus and infectious mononucleosis. N. Engl. J. Med. 288, 263–264 (1973 a)PubMedCrossRefGoogle Scholar
  59. Henle, W., Henle, G.: Epstein-Barr virus (EBV)-related serology in Hodgkin’s disease. Natl. Cancer Inst. Monogr. 36, 79–84 (1973 b)PubMedGoogle Scholar
  60. Henle, W., Hummeler, K., Henle, G.: Antibody coating and agglutination of virus particles separated from the EB3 line of Burkitt lymphoma cells. J. Bacteriol. 92, 269–271 (1966)PubMedGoogle Scholar
  61. Henle, W., Diehl, V., Kohn, G., zur Hausen, H., Henle, G.: Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells. Science 157, 1064–1065 (1967)PubMedCrossRefGoogle Scholar
  62. Henle, W., Henle, G., Zajac, B., Pearson, G., Waubke, R., Scriba, M.: Differential reactivity of human sera with EBV-induced “early antigens”. Science 169, 188–190 (1970 a)PubMedCrossRefGoogle Scholar
  63. Henle, W., Henle, G., Scriba, M., Joyner, C. R., Harrison, F. Jr.), von Essen, R., Paloheimo, J., Klemola, E.: Antibody responses to the Epstein-Barr virus and cytomegaloviruses after open-heart and other surgery. N. Engl. J. Med. 282, 1068–1074 (1970b)PubMedCrossRefGoogle Scholar
  64. Henle, W., Henle, G., Niederman, J. C., Klemola, E., Haltia, K.: Antibodies to early antigens induced by Epstein-Barr virus in infectious mononucleosis. J. Infect. Dis. 124, 58–67 (1971)PubMedCrossRefGoogle Scholar
  65. Henle, W., Henle, G., Horwitz, C. A.: Epstein-Barr virus-specific diagnostic tests in infectious mononucleosis. Human Pathol. 5, 551–565 (1974 a)CrossRefGoogle Scholar
  66. Henle, W., Guerra, A., Henle, G.: False negative and prozone reactions in tests for antibodies to Epstein-Barr virus-associated nuclear antigen. Int. J. Cancer 13, 751–754 (1974b)PubMedCrossRefGoogle Scholar
  67. Hewetson, J. F., Rocchi, G., Henle, W., Henle, G.: Neutralizing antibodies against Epstein-Barr virus in healthy populations and patients with infectious mononucleosis. J. Infect. Dis. 128, 283–289 (1973)PubMedCrossRefGoogle Scholar
  68. Hinuma, Y., Kohn, M., Yamaguchi, J., Wudarski, D. J., Blakesee, J. R. Jr), Grace, J. T. (Jr.): Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line. J. Virol. 1, 1045–1051 (1967)PubMedGoogle Scholar
  69. Hirshaut, Y., Christenson, W. N., Perlmutter, J. C.: Prospective study of herpes-like virus role in infectious mononucleosis. Clin. Res. 19, 459–463 (1971)Google Scholar
  70. Hoagland, R. J.: The transmission of infectious mononucleosis. Am. J. Med. Sci. 229, 262–272 (1955)PubMedCrossRefGoogle Scholar
  71. Horwitz, C. A., Henle, W., Henle, G., Schmitz, H.: Clinical evaluation of patients with infectious mononucleosis and development of antibodies to the R component of the Epstein-Barr virus-induced early antigen complex. Am. J. Med. 58, 330–338 (1975)PubMedCrossRefGoogle Scholar
  72. Horwitz, C. A., Henle, W., Henle, G., Segal, M., Arnold, T., Lewis, F. B., Zanick, D., Ward, P. C. J.: Clinical and laboratory evaluation of elderly patients with heterophil-antibody positive infectious mononucleosis; report of seven patients, ages 40–78. Am. J. Med. 61, 333–339 (1976a)PubMedCrossRefGoogle Scholar
  73. Horwitz, C., Henle, W., Henle, G., Polesky, H., Wexler, H., Ward, P.: The specificity of heterophil antibodies and healthy donors with no or minimal signs of infectious mononucleosis. Blood 47, 91–98 (1976b)PubMedGoogle Scholar
  74. Horwitz, C. A., Henle, W., Henle, G., Polesky, H., Balfour, H. H. (Jr.), Siem, R. A., Borken, S., Ward, P. C. J.: Heterophil-negative infectious mononucleosis and mononucleosis-like illnesses: laboratory confirmation of 43 cases. Am. J. Med. 63, 947–956 (1977)PubMedCrossRefGoogle Scholar
  75. Huang, D. P., Ho, J. H. C., Henle, W., Henle, G.: Demonstration of EBV-associated nuclear antigen in NPC cells from fresh biopsies. Int. J. Cancer 14, 580–588 (1974)PubMedCrossRefGoogle Scholar
  76. Hutt, L. M., Huang, Y. T., Dascomb, H. E., Pagano, J. S.: Enhanced destruction of lymphoid cell lines by peripheral blood leukocytes taken from patients with acute infectious mononucleosis. J. Immunol. 115, 243–248 (1975)PubMedGoogle Scholar
  77. Irie, R. F., Irie, K., Morton, D.: Natural antibody in human serum to a neoantigen in human cultured cells grown in fetal calf serum. J. Natl. Cancer Inst. 52; 1051–1057 (1974)PubMedGoogle Scholar
  78. Joncas, J., Mitnyan, C.: Serologic response of the EBV antibodies in pediatric cases of infectious mononucleosis and their contacts. Can. Med. Assoc. J. 102, 1260–1263 (1970)PubMedGoogle Scholar
  79. Jondal, M., Klein, G.: Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes. J. Exp. Med. 138, 1365–1378 (1973)PubMedCrossRefGoogle Scholar
  80. Jondal, M.: Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens. I. Reactivity in sera from normal persons and from patients with acute infectious mononucleosis. Clin. Exp., Immunol. 25, 1–10 (1976)Google Scholar
  81. Kalter, S. S., Heberling, R. L., Ratner, J. J.: EBV antibody in sera of non-human primates. Nature 238, 353–354 (1972)PubMedCrossRefGoogle Scholar
  82. Klein, G., Vonka, V.: Relationship between the Epstein-Barr virus (EBV) determined complement-fixing antigen and the nuclear antigen (EBNA) detected by anti-complement fluorescence. J. Nat. Cancer Inst. 53, 1645–1646 (1974)PubMedGoogle Scholar
  83. Klein, G., Clifford, P., Klein, E., South, R. T., Minowada, J., Kourilsky, F., Burchenal, J. H.: Membrane immunofluorescence reactions of Burkitt lymphoma cells from biopsy specimens and tissue cultures. J. Natl., Cancer Inst. 39, 1027–1044 (1967)Google Scholar
  84. Klein, G., Pearson, G., Nadkarni, J. S., Nadkarni, J. J., Klein, E., Henle, G., Henle, W., Clifford, P.: Relation between Epstein-Barr viral and cell membrane immunofluorescence of Burkitt tumor cells. I. Dependence of cell membrane immunofluorescence on presence of EB virus. J. Exp. Med. 128, 1011–1020 (1968 a)PubMedCrossRefGoogle Scholar
  85. Klein, G., Pearson, G., Henle, G., Henle, W., Diehl, V., Niederman, J. C.: Relation between Epstein-Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. II. Comparison of cells and sera from patients with Burkitt’s lymphoma and infectious mononucleosis. J. Exp. Med. 128, 1021–1030 (1968 b)PubMedCrossRefGoogle Scholar
  86. Klein, G., Pearson, G., Henle, G., Henle, W., Goldstein, G., Clifford, P.: Relation between Epstein-Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. III. Comparison of blocking and direct membrane immunofluorescence and anti-EBV reactivities of different sera. J. Exp. Med. 129, 697–705 (1969)PubMedCrossRefGoogle Scholar
  87. Klein, G., Giovanella, B. C., Lindahl, T., Fialkow, P. J., Singh, S., Stehlin, J. S.: Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx. Proc. Natl. Acad. Sci. USA 71, 4737–4741 (1974)PubMedCrossRefGoogle Scholar
  88. Klein, G., Svedmyr, E., Jondal, M., Persson, P. O.: EBV-determined nuclear antigen (EBNA)-positive cells in the peripheral blood of infectious mononucleosis patients. Int. J. Cancer 17, 21–26 (1976)PubMedCrossRefGoogle Scholar
  89. Klemola, E., Kääriäinen, L., von Essen, R., Haltia, K., Koivuniemi, A., von Bonsdorff, C-H.: Further studies on cytomegalovirus mononucleosis in previously healthy individuals. Acta Med. Scand. 182, 311–322(1967)PubMedCrossRefGoogle Scholar
  90. Klemola, E., von Essen, R., Henle, G., Henle, W.: Infectious mononucleosis-like disease with negative heterophil agglutination test. Clinical features in relation to Epstein-Barr virus and cytomegalovirus antibodies. J. Infect. Dis. 121, 608–614 (1970)PubMedCrossRefGoogle Scholar
  91. Lange, B. J., Berman, P. H., Bender, J., Henle, W., Hewetson, J. F.: Encephalitis in infectious mononucleosis: diagnostic considerations. Pediatrics 58, 877–880 (1976)PubMedGoogle Scholar
  92. Lee, C. L., Davidsohn, I.: Serologic test for infectious mononucleosis. Chicago: American Society of Clinical Pathologists Commission on Continuing Education 1972Google Scholar
  93. Lee, C. L., Davidsohn, I., Panczyszyn, O.: Horse agglutinins in infectious mononucleosis. II. The spot test. Am. J. Clin. Pathol. 49, 12–18 (1968)PubMedGoogle Scholar
  94. Leibold, W., Flanagan, T. D., Menezes, J., Klein, G.: Induction of Epstein-Barr virus (EBV)-associated nuclear antigen (EBNA) during in vitro transformation of human lymphoid cells. J. Natl. Cancer Inst. 54, 65–68 (1975)PubMedGoogle Scholar
  95. Lemon, S. M., Hutt, L. M., Shaw, J. E., Li, J-L., Pagano, J. S.: Replication of EBV in epithelial cells during infectious mononucleosis. Nature 268, 268–270 (1977)PubMedCrossRefGoogle Scholar
  96. Lenoir, J. L., de-Thé, G., Virelizier, J. L., Griscelli, C.: Epstein-Barr virus nuclear antigen (EBNA) positive cells in a lymph node of a child with severe primary EBV infection. In: Oncogenesis and herpesviruses III. de-Thé, G., Henle, W., Rapp, F. (eds.), pp. 733–738. Lyon: IARC 1978Google Scholar
  97. Levy, J. A., Henle, G.: Indirect immunofluorescence tests with sera from African children and cultured Burkitt lymphoma cells. J. Bacteriol. 92, 275–276 (1966)PubMedGoogle Scholar
  98. Leyton, G. B.: Ox-cell hemolysins in human serum. J. Clin. Pathol. 5, 324–328 (1952)PubMedCrossRefGoogle Scholar
  99. Mangi, R. J., Niederman, J. C., Kelleher, J. E. Jr.), Dwyer, J. M., Evans, A. S., Kantor, F. S.: Depression of cell mediated immunity during acute infectious mononucleosis. N. Eng. J. Med. 291, 1149–1153 (1974)CrossRefGoogle Scholar
  100. Mason, J. K.: An ox cell haemolysin test for the diagnosis of infectious mononucleosis. J. Hyg. (Camb.) 49, 471–481 (1951)CrossRefGoogle Scholar
  101. Mayyasi, S. A., Schidlovsky, G., Bulfone, L. M., Buscheck, F. T.: The coating reaction of the herpes-type virus isolated from malignant tissues with an antibody present in sera. Cancer Res. 27, 2020–2024 (1967)PubMedGoogle Scholar
  102. Miller, G.:Epstein-Barr herpesvirus and infectious mononucleosis. Progr. Med. Virol. 20, 84–112 (1975)Google Scholar
  103. Miller, G., Lisco, H., Kohn, H. I., Stitt, D.: Establishment of cell lines from normal adult human blood leukocytes by exposure to Epstein-Barr virus and neutralization by human sera with Epstein-Barr virus antibody. Proc. Soc. Exp. Biol. Med. 137, 1459–1465 (1971)PubMedGoogle Scholar
  104. Miller, G., Niederman, J. C., Stitt, D. L.: Infectious mononucleosis: appearance of neutralizing antibody to Epstein-Barr virus measured by inhibition of formation of lymphoblastoid cell lines. J. Infect. Dis. 125, 403–406 (1972)PubMedCrossRefGoogle Scholar
  105. Miller, G., Niederman, J. C., Andrews, L.: Prolonged oropharyngeal excretion of EB virus following infectious mononucleosis. N. Engl. J. Med. 137, 140–147 (1973)Google Scholar
  106. Miller, G., Robinson, J., Heston, L., Lipman, M.: Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection and interference. Proc. Natl. Acad. Sci. USA 71, 4006–4010 (1974)PubMedCrossRefGoogle Scholar
  107. Moore, G. E., Gerner, R. E., Franklin, H. A.: Culture of normal human leukocytes. J. Am. Med. Assoc. 199, 519–524 (1967)CrossRefGoogle Scholar
  108. Moss, D. J., Pope, J. H.: EB virus-associated nuclear antigen production and cell proliferation in adult peripheral leukocytes inoculated with the QIMR-WIL strain of EB virus. Int. J. Cancer 15, 503–511 (1975)PubMedCrossRefGoogle Scholar
  109. Nadkarni, J. S., Nadkarni, J. J., Clifford, P., Manolov, G., Fenyö, E. N., Klein, E.: Characteristics of new cell lines derived from Burkitt’s lymphomas. Cancer 23, 64–79 (1968)CrossRefGoogle Scholar
  110. Nadkarni, J. S., Nadkarni, J. J., Klein, G., Henle, W., Henle, G., Clifford, P.: EB viral antigens in Burkitt tumor biopsies and early cultures. Int. J. Cancer 6, 10–17 (1970)PubMedCrossRefGoogle Scholar
  111. Niederman, J. C., Scott, R. B.: Studies on infectious mononucleosis: Attempts to transmit the disease to human volunteers. Yale J. Biol. Med. 38, 1–10 (1965)PubMedGoogle Scholar
  112. Niederman, J. C., McCollum, R. W., Henle, G., Henle, W.: Infectious mononucleosis. J. Am. Med. Assoc. 203, 139–143 (1968)CrossRefGoogle Scholar
  113. Niederman, J. C., Evans, A. S., Subramanyan, M. S., McCollum, R. W.: Prevalence incidence and persistence of EB virus antibody in young adults. N. Eng. J. Med. 282, 361–365 (1970)CrossRefGoogle Scholar
  114. Niederman, J. C., Miller, G., Pearson, H. A., Pagano, J. S., Dowalibi, J. M.: Infectious mononucleosis. Epstein-Barr virus shedding in saliva and the oropharynx. N. Engl. J. Med. 294, 1355–1359 (1976)PubMedCrossRefGoogle Scholar
  115. Nikoskelainen, J., Hänninen, P.: Antibody responses to Epstein-Barr virus in infectious mononucleosis. Infect. Immun. 11, 42–51 (1975)PubMedGoogle Scholar
  116. Nikoskelainen, J., Leikola, J., Klemola, E.: IgM antibodies specific for Epstein-Barr virus in infectious mononucleosis, without heterophil antibodies. Br. Med. J. 1974 IV, 72–75CrossRefGoogle Scholar
  117. Nilsson, K., Klein, G., Henle, W., Henle, G.: The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV. Int. J. Cancer 8, 443–450 (1971)PubMedGoogle Scholar
  118. Nonoyama, M., Pagano, J. S.: Detection of Epstein-Barr viral genome in non-productive cells. Nature 233, 103–106 (1971)Google Scholar
  119. Pattengale, P. K., Smith, R. W., Perlin, E.: Atypical lymphocytes in acute infectious mononucleosis. Identification by multiple T and B lymphocyte markers. N. Engl. J. Med. 291, 1145–1148 (1974 a)PubMedCrossRefGoogle Scholar
  120. Pattengale, P. K., Gerber, P., Smith, R. W.: B-cell characteristics of human peripheral and cord blood lymphocytes transformed by Epstein-Barr virus. J. Natl. Cancer Inst. 52, 1081–1086 (1974b)PubMedGoogle Scholar
  121. Paul, J. R., Bunnell, W. W.: The presence of heterophile antibodies in infectious mononucleosis. Am. J. Med. Sci. 183, 80–104 (1932)CrossRefGoogle Scholar
  122. Pearson, G.: In vitro and in vivo investigations on antibody-dependent cellular cytotoxity. Curr. Top. Microbiol. Immunol. 80, 65–96 (1978)PubMedGoogle Scholar
  123. Pearson, G. R., Orr, T. W.: Antibody-dependent lymphocyte cytotoxicity against cells expressing Epstein-Barr virus antigens. J. Natl. Cancer Inst. 56, 485–488 (1976)PubMedGoogle Scholar
  124. Pearson, G., Dewey, F., Klein, G., Henle, G., Henle, W.: Relation between neutralization of Epstein-Barr virus and antibodies to cell membrane antigens induced by the virus. J. Natl. Cancer Inst 45, 989–995 (1970)PubMedGoogle Scholar
  125. Pereira, M. S., Field, A. M., Blake, J. M., Rodgers, F. G., Bailey, L. A., Davies, J. R.: Evidence for oral excretion of EB virus in infectious mononucleosis. Lancet 1972 I, 710–711CrossRefGoogle Scholar
  126. Piessens, W. F., Schur, P. H., Moloney, W. C., Churchill, W. H.: Lymphocyte surface immunoglobulins. Distribution and frequency in lymphoproliferative diseases. N. Engl. J. Med. 288, 176–180 (1973)PubMedCrossRefGoogle Scholar
  127. Pope, J. H.: Establishment of cell lines from peripheral leukocytes in infectious mononucleosis. Nature 216, 810–811 (1967)PubMedCrossRefGoogle Scholar
  128. Pope, J. H., Home, M. K., Wetters, E. J.: Significance of a complement-fixing antigen associated with herpes-like virus and detected in the Raji cell line. Nature 222, 166–167 (1969 a)CrossRefGoogle Scholar
  129. Pope, J. H., Home, M. K., Scott, W.: Identification of the filtrable leukocyte-transforming factor of QIMR-WIL cells as herpes-like virus. Int. J. Cancer 4, 255–260 (1969 b)PubMedCrossRefGoogle Scholar
  130. Pulvertaft, R. J. V.: Cytology of Burkitt’s tumor (African lymphoma). Lancet 1964 I, 238–240CrossRefGoogle Scholar
  131. Reedman, B. M., Klein, G.: Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int. J. Cancer 11, 499–520 (1973)PubMedCrossRefGoogle Scholar
  132. Rickinson, A. B., Jarvis, J. E., Crawford, D. H., Epstein, M. A.: Observations on the type of infection by Epstein-Barr virus in peripheral lymphoid cells of patients with infectious mononucleosis. Int. J. Cancer 14, 704–715 (1974)PubMedCrossRefGoogle Scholar
  133. Rickinson, A. B., Finerty, S., Epstein, M. A.: Comparative studies on adult donor lymphocytes infected by EB virus in vivo and in vitro. Origin of transformed cells arising in co-cultures with foetal lymphocytes. Int. J. Cancer 19, 775–782 (1977)PubMedCrossRefGoogle Scholar
  134. Rickinson, A. B., Finerty, S., Epstein, M. A.: Inhibition by phosphonoacetate of the in vitro outgrowth of Epstein-Barr virus genome-containing cell lines from the blood of infectious mononucleosis patients. In: Oncogenesis and herpesviruses III. de-Thé, G., Henle, W., Rapp F. (eds.), pp. 721–728. Lyon: IARC 1978Google Scholar
  135. Robinson, J., Miller, G.: Assay for Epstein-Barr virus based on stimulation of DNA synthesis in mixed leukocytes from umbilical cord blood. J. Virol. 15, 1065–1072 (1975)PubMedGoogle Scholar
  136. Rocchi, G., Hewetson, J. F.: A practical and quantitative micro test for determination of neutralizing antibodies against Epstein-Barr virus. J. Gen. Virol. 18, 385–391 (1973)PubMedCrossRefGoogle Scholar
  137. Rocchi, G., Hewetson, J., Henle, W.: Specific neutralizing antibodies in Epstein-Barr virus associated diseases. Int. J. Cancer 11, 637–647 (1973)PubMedCrossRefGoogle Scholar
  138. Rocchi, G., de Felici, A., Ragona, G., Heinz, A.: Quantitative evaluation of Epstein-Barr-Virus-infected mononuclear peripheral blood leukocytes in infectious mononucleosis. N. Engl. J. Med. 296, 132–134 (1977)PubMedCrossRefGoogle Scholar
  139. Royston, I., Sullivan, J. L., Perlman, P. O., Perlin, E.: Cell-mediated immunity to Epstein-Barr virus-transformed lymphoblastoid cells in acute infectious mononucleosis. N. Eng. J. Med. 293, 1159–1163 (1975)CrossRefGoogle Scholar
  140. Sawyer, R. N., Evans, A. S., Niederman, J. C., McCollum, R. W.: Prospective studies of a group of Yale University freshmen. I. Occurence of infectious mononucleosis. J. Infect. Dis. 123, 263–270 (1971)PubMedCrossRefGoogle Scholar
  141. Schmitz, H., Scherer, M.: IgM antibodies to Epstein-Barr virus in infectious mononucleosis. Arch. Ges. Virusforsch. 37, 332–339 (1972)PubMedCrossRefGoogle Scholar
  142. Sheldon, P. J., Papamichael, M., Hemsted, E. H., Holborow, E. J.: Thymic origin of atypical lymphoid cells in infectious mononucleosis. Lancet 1973 I, 1153–115CrossRefGoogle Scholar
  143. Shope, T., Dechairo, D., Miller, G.: Malignant lymphoma in cotton-top marmosets following inoculation of Epstein-Barr virus. Proc. Natl. Acad. Sci. USA 70, 2487–2491 (1973)PubMedCrossRefGoogle Scholar
  144. Silvestre, D., Ernberg, I., Neauport-Sautes, C., Kourilsky, F. M., Klein, G.: Differentiation between early and late membrane antigen on human lymphoid cell lines infected with Epstein-Barr virus. II. Immunoelectron microscopy. J. Natl. Cancer Inst. 53, 67–74 (1974)PubMedGoogle Scholar
  145. Sohier, R., Lepine, P., Sautter, V.: Recherches sur la transmission experimentale de la mononucleose au singe et à l’homme. Ann. Inst. Pasteur 65, 50–62 (1940)Google Scholar
  146. Strauch, B., Andrews, L., Siegel, N., Miller, G.: Oropharyngeal excretion of Epstein-Barr virus by renal transplant recipients and other patients treated with immunosuppressive drugs. Lancet 1974 I, 234–237CrossRefGoogle Scholar
  147. Sulit, H. L., Golub, S. H., Irie, R. F., Gupta, R. K., Grooms, G. A., Morton, D. L.: Human tumor cells grown in fetal calf serum and human serum: Influences on the tests for lymphocyte cyco toxicity, serum blocking and serum arming effects. Int. J. Cancer 17, 461–468 (1976)PubMedCrossRefGoogle Scholar
  148. Summers, W. C., Klein, G.: Inhibition of EBV DNA synthesis and late gene expression by phosphonoacetic acid. J. Virol. 18, 151–155 (1976)PubMedGoogle Scholar
  149. Svedmyr, E., Jondal, M.: Cytotoxic effector cells specific for B cell lines transformed by Epstein-Barr virus are present within patients with infectious mononucleosis. Proc. Natl. Acad. Sci. USA 72, 1622–1626 (1975)PubMedCrossRefGoogle Scholar
  150. Taylor, A. W.: Effects of glandular fever in acute leukemia. Br. Med. J. 1953 I, 589–593CrossRefGoogle Scholar
  151. Tischendorf, P., Shramek, G. J., Balagtas, R. C., Deinhardt, F., Knospe, W. H., Noble, G. R., Maynard, J. E.: Development and persistence of immunity to Epstein-Barr virus in man. J. Infect. Dis. 122, 401–409 (1970)PubMedCrossRefGoogle Scholar
  152. Turner, A. R., MacDonald, R. N., Cooper, B. A.: Transmission of infectious mononucleosis by transfusion of pre-illness plasma. Ann. Intern. Med. 77, 751–753 (1972)PubMedGoogle Scholar
  153. University Health Physicians and P.H.L.S. Laboratories: Infectious mononucleosis and its relation to EB virus antibody. Br. Med. J. 1971 IV, 643–646Google Scholar
  154. Virolainen, M., Andersson, L. C., Lalia, M., Van Essen, R.: T-lymphocyte proliferation in mononucleosis. Clin. Immunol. Immunopathol. 2, 114–120 (1973)PubMedCrossRefGoogle Scholar
  155. Vonka, V., Benyesh-Melnick, M., McCombs, R. M.: Antibodies in human sera to soluble and viral antigens found in Burkitt’s lymphoma and other lymphoblastoid cell lines. J. Natl, Cancer Inst. 44, 865–872 (1970)Google Scholar
  156. Vonka, V., Vlckova, I., Zavadova, H., Kouba, K., Lazonska, Y., Duben, J.: Antibodies to EB virus capsid antigen and soluble antigen of lymphoblastoid cells in infectious mononucleosis. Int. J. Cancer 9, 529–535 (1972)PubMedCrossRefGoogle Scholar
  157. Wahren, B., Espmark, A., Waldén, G.: Serologic studies on cytomegalovirus infection in relation to infectious mononucleosis and similar conditions. Scand. J. Infect. Dis. 1, 145–151 (1969)PubMedGoogle Scholar
  158. Wahren, B., Espmark, A., Lantorp, K., Sterner, G.: EBV antibodies in family contacts of patients with infectious mononucleosis. Proc. Soc. Exp. Biol. Med. 133, 934–939 (1970)PubMedGoogle Scholar
  159. Werner, J., Pinto, C. A., Haff, R. F., Henle, W., Henle, G.: Responses of gibbons (Hylobates Lar) to inoculation of Epstein-Barr virus (EBV). J. Infect. Dis. 126, 678–681 (1972)PubMedCrossRefGoogle Scholar
  160. Wilson, W. E. C., Kirkpatrick, C. H., Talmadge, D. W.: Suppression of immunologic responsiveness in uremia. Ann. Intern. Med. 62, 1–14 (1965)Google Scholar
  161. Wising, P. J.: A study of infectious mononucleosis (Pfeiffer’s disease) from the etiological point of view. Acta Med. Scand. Suppl. 133, 1–102 (1942)Google Scholar
  162. Wolf, H., zur Hausen, H., Becker, V.: EB viral genomes in epithelial nasopharyngeal carcinoma cells. Nature 244, 245–247 (1973)Google Scholar
  163. Wolf, H., zur Hausen, H., Klein, G., Becker, V., Henle, G., Henle, W.: Attempts to detect virus-specific DNA sequences in human tumors. III. Epstein-Barr viral DNA in non-lymphoid nasopharyngeal carcinoma cells. Med. Microbiol. Immunol. 161, 15–21 (1975)PubMedCrossRefGoogle Scholar
  164. zur Hausen, H., Schulte-Holthausen, H.: Presence of EB virus nucleic acid homology in a “virus-free” line of Burkitt tumor cells. Nature 227, 245–248 (1970)PubMedCrossRefGoogle Scholar
  165. zur Hausen, H., Henle, W., Hummeler, K., Diehl, V., Henle, G.: Comparative study of cultured Burkitt tumor cells by immunofluorescence, autoradiography and electron microscopy. J. Virol. 1, 830–837 (1967)PubMedGoogle Scholar
  166. zur Hausen, H., Diehl, V., Wolf, H., Schulte-Holthausen, H., Schneider, U.: Occurence of Epstein-Barr virus genomes in human lymphoblastoid cell lines. Nature New Biol. 237, 189–190 (1972)Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1979

Authors and Affiliations

  • G. Henle
    • 1
  • W. Henle
    • 1
  1. 1.Division of Virology, The Joseph Stokes, Jr. Research Institute at The Children’s Hospital of Philadelphia, School of MedicineUniversity of PennsylvaniaPhiladelphiaUSA

Personalised recommendations